GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1101 - 1125 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgM Patient 1 22 moderate
G18057VI
68
IgG Patient 1 6 moderate
G42666HT
68
IgM Patient 2 24 mild
G00048MO
68
IgM Patient 2 24 mild
G94435QH
68
IgM Patient 2 3 mild
G00048MO
68
IgM Patient 2 3 mild
G91237TK
68
IgG Patient 3 -180 mild
G82096UQ
68
IgG Patient 3 11 mild
G03499BP
68
IgM Patient 3 -180 mild
G28868ZC
68
IgG Patient 3 4 mild
G78074HX
68
IgG Patient 3 4 mild
G92823JK
68
IgM Patient 3 4 mild
G47566FL
68
IgG Patient 1 10 moderate
G47362BJ
69
IgG Patient 1 22 moderate
G14569AR
69
IgM Patient 1 10 moderate
G14988WV
69
IgM Patient 1 10 moderate
G16579HJ
69
IgM Patient 1 22 moderate
G78074HX
69
IgM Patient 1 6 moderate
G10133VD
69
IgG Patient 2 24 mild
G24617OK
69
IgG Patient 2 3 mild
G82096UQ
69
IgM Patient 3 4 mild
G86541PE
69
IgM Patient 1 10 moderate
G72424VO
70
IgG Patient 2 15 mild
G65889KE
70
IgM Patient 3 -180 mild
G31265MS
70
IgM Patient 3 -180 mild
G82348BZ
70

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024